Biotech news

Latest breaking stories, features and analysis

Biogen‘s Alzheimer treatment triggers debate regarding its real-world benefits
  • Debate growing regarding whether the cost of Biogen’s AD treatment can offer real-world benefits
  • Biogen’s Alzheimer’s treatment costs $56,000
  • Wedbush analyst has a “Neutral” rating on Biogen stock
July 22, 2021

Market analysis

Biogen skyrockets after Alzheimer’s drug approval – time to buy?
June 8, 2021

More breaking stories

June 8, 2021
June 8, 2021
May 24, 2021
May 24, 2021
May 11, 2021
March 1, 2021
February 5, 2021
February 3, 2021
November 27, 2020
November 16, 2020